Neuroone Medical Technologies Stock Performance
| NMTC Stock | USD 0.83 0.06 6.74% |
On a scale of 0 to 100, Neuroone Medical holds a performance score of 5. The company secures a Beta (Market Risk) of 2.05, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Neuroone Medical will likely underperform. Please check Neuroone Medical's potential upside and the relationship between the skewness and period momentum indicator , to make a quick decision on whether Neuroone Medical's current price movements will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Neuroone Medical Technologies are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Neuroone Medical exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:3 | Last Split Date 2021-04-01 |
1 | Can NeuroOne Medical Technologies Corporation stock hit analyst price targets - July 2025 Spike Watch Low Risk High Win Rate Stock Picks - newser.com | 11/18/2025 |
2 | NeuroOne Announces Initial Successful Cases Completed With OneRF Trigeminal Nerve Ablation System at the University Hospitals in Cleveland | 12/09/2025 |
3 | Neuroone Medical is to drop even more in January | 12/16/2025 |
4 | Novogradac Conference to Discuss Turning NMTC Permanence into Long-Term Impact | 12/17/2025 |
5 | Insider Trading | 12/18/2025 |
6 | NeuroOne Medical Technologies Corp Q4 2025 Earnings Call Highlights Record Revenue ... | 12/19/2025 |
7 | NeuroOne Medical Technologies Corporation Q4 2025 Earnings Call Transcript | 12/23/2025 |
8 | Disposition of 253 shares by Mark Christianson of Neuroone Medical at 0.758 subject to Rule 16b-3 | 12/31/2025 |
9 | Heartland Renaissance Fund Secures New Markets Tax Credit Allocation to Fuel Economic Growth | 01/08/2026 |
10 | Disposition of 71325 shares by Rosa David A of Neuroone Medical at 1.16 subject to Rule 16b-3 | 01/21/2026 |
| Begin Period Cash Flow | 1.5 M | |
| Total Cashflows From Investing Activities | -81.7 K |
Neuroone Medical Relative Risk vs. Return Landscape
If you would invest 72.00 in Neuroone Medical Technologies on November 4, 2025 and sell it today you would earn a total of 11.00 from holding Neuroone Medical Technologies or generate 15.28% return on investment over 90 days. Neuroone Medical Technologies is currently generating 0.3557% in daily expected returns and assumes 5.0394% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than Neuroone, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Neuroone Medical Target Price Odds to finish over Current Price
The tendency of Neuroone Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.83 | 90 days | 0.83 | about 24.13 |
Based on a normal probability distribution, the odds of Neuroone Medical to move above the current price in 90 days from now is about 24.13 (This Neuroone Medical Technologies probability density function shows the probability of Neuroone Stock to fall within a particular range of prices over 90 days) .
Neuroone Medical Price Density |
| Price |
Predictive Modules for Neuroone Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neuroone Medical Tec. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neuroone Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neuroone Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Neuroone Medical is not an exception. The market had few large corrections towards the Neuroone Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Neuroone Medical Technologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Neuroone Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.03 | |
β | Beta against Dow Jones | 2.05 | |
σ | Overall volatility | 0.1 | |
Ir | Information ratio | 0.02 |
Neuroone Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Neuroone Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Neuroone Medical Tec can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Neuroone Medical Tec had very high historical volatility over the last 90 days | |
| Neuroone Medical Tec has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 12.1 M. Net Loss for the year was (3.61 M) with loss before overhead, payroll, taxes, and interest of (1.23 M). | |
| Neuroone Medical Technologies currently holds about 10.18 M in cash with (2.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63. | |
| Latest headline from MacroaxisInsider: Disposition of 71325 shares by Rosa David A of Neuroone Medical at 1.16 subject to Rule 16b-3 |
Neuroone Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Neuroone Stock often depends not only on the future outlook of the current and potential Neuroone Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neuroone Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 40.2 M | |
| Cash And Short Term Investments | 6.6 M |
Neuroone Medical Fundamentals Growth
Neuroone Stock prices reflect investors' perceptions of the future prospects and financial health of Neuroone Medical, and Neuroone Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neuroone Stock performance.
| Return On Equity | -0.95 | ||||
| Return On Asset | -0.45 | ||||
| Profit Margin | (0.81) % | ||||
| Operating Margin | (1.11) % | ||||
| Current Valuation | 37.57 M | ||||
| Shares Outstanding | 50 M | ||||
| Price To Earning | (23.53) X | ||||
| Price To Book | 6.20 X | ||||
| Price To Sales | 3.70 X | ||||
| Revenue | 12.1 M | ||||
| Gross Profit | (1.23 M) | ||||
| EBITDA | (3.01 M) | ||||
| Net Income | (3.61 M) | ||||
| Cash And Equivalents | 10.18 M | ||||
| Cash Per Share | 0.63 X | ||||
| Total Debt | 266.81 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 13.42 X | ||||
| Book Value Per Share | 0.16 X | ||||
| Cash Flow From Operations | (2.84 M) | ||||
| Earnings Per Share | (0.16) X | ||||
| Market Capitalization | 33.89 M | ||||
| Total Asset | 10.79 M | ||||
| Retained Earnings | (78.61 M) | ||||
| Working Capital | 7.92 M | ||||
| Current Asset | 94.49 M | ||||
| Current Liabilities | 18.26 M | ||||
About Neuroone Medical Performance
By analyzing Neuroone Medical's fundamental ratios, stakeholders can gain valuable insights into Neuroone Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Neuroone Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Neuroone Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 236.26 | 224.44 | |
| Return On Tangible Assets | (150.49) | (142.97) | |
| Return On Capital Employed | 0.84 | 0.88 | |
| Return On Assets | (20.23) | (21.25) | |
| Return On Equity | 1.00 | 1.05 |
Things to note about Neuroone Medical Tec performance evaluation
Checking the ongoing alerts about Neuroone Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neuroone Medical Tec help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Neuroone Medical Tec had very high historical volatility over the last 90 days | |
| Neuroone Medical Tec has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 12.1 M. Net Loss for the year was (3.61 M) with loss before overhead, payroll, taxes, and interest of (1.23 M). | |
| Neuroone Medical Technologies currently holds about 10.18 M in cash with (2.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63. | |
| Latest headline from MacroaxisInsider: Disposition of 71325 shares by Rosa David A of Neuroone Medical at 1.16 subject to Rule 16b-3 |
- Analyzing Neuroone Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neuroone Medical's stock is overvalued or undervalued compared to its peers.
- Examining Neuroone Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Neuroone Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neuroone Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Neuroone Medical's stock. These opinions can provide insight into Neuroone Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Neuroone Stock analysis
When running Neuroone Medical's price analysis, check to measure Neuroone Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuroone Medical is operating at the current time. Most of Neuroone Medical's value examination focuses on studying past and present price action to predict the probability of Neuroone Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuroone Medical's price. Additionally, you may evaluate how the addition of Neuroone Medical to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |